News Corporation filed a Form 8-K on August 10, 2026, reporting the attachment of share repurchase transaction disclosures provided to the Australian Securities Exchange on dates noted in the accompanying exhibits.
Sionna Therapeutics, Inc. filed a Form 8-K on August 10, 2026, announcing topline data from its PreciSION CF Phase 2a proof-of-concept trial of SION-719 and its Phase 1 trial of SION-451-based proprietary dual combinations, along with a corporate update on next steps.
Tenax Therapeutics, Inc. filed a current report on Form 8-K on August 10, 2026, announcing topline results from its Phase 3 LEVEL clinical trial of TNX-103 in patients with PH-HFpEF, along with a conference call and live webcast held the same day.
Surgery Partners, Inc. filed a current report on August 10, 2026, announcing financial results for the three and six months ended June 30, 2026, along with a scheduled investor conference call for the same date.
Liberty Media Corporation filed an 8-K with the U.S. Securities and Exchange Commission on August 10, 2026, disclosing a proposed offering of $600 million aggregate principal amount of convertible senior notes due 2032.
SunocoCorp LLC filed a current report on August 10, 2026, disclosing plans for senior management to participate in investor meetings at two energy industry conferences in August and September 2026.
GCM Grosvenor Inc. filed a current report on August 10, 2026, disclosing financial results for the three and six months ended June 30, 2026, with a press release and earnings presentation furnished as exhibits.
AbCellera Biologics Inc. filed a current report on August 10, 2026, announcing positive top-line results from the Phase 2 portion of its Phase 1/2 clinical trial evaluating ABCL635, an investigational neurokinin 3 receptor antagonist antibody.
MarineMax, Inc. filed a current report on August 10, 2026, disclosing that on August 9, 2026, it entered into an Agreement and Plan of Merger with SHM Holdco, LLC and Intrepid Holdco, Inc., affiliates of Safe Harbor Marinas, LLC, a portfolio company of Blackstone …
Replimune Group, Inc. filed a current report on August 10, 2026, disclosing that on August 9, 2026, the company entered into an underwriting agreement for a public offering of common stock and pre-funded warrants, with estimated net proceeds of approximately $140.5 million.